Surgery: light – thermal – and electrical application – Light – thermal – and electrical application – Electrical therapeutic systems
Reexamination Certificate
2011-08-30
2011-08-30
Layno, Carl H (Department: 3766)
Surgery: light, thermal, and electrical application
Light, thermal, and electrical application
Electrical therapeutic systems
C607S115000, C607S116000, C607S117000, C607S135000, C607S139000, C600S544000
Reexamination Certificate
active
08010201
ABSTRACT:
A system for removing charged particles from the brain in which a cannula with a distal anode, a proximal cathode and a vacuum are used. The cannula also comprises a fluid delivery port that is functionally connected to a vacuum, and holes with the distal end of the cannula. The charged species in the brain tissue are drawn to the anode that is on the distal end of the probe, when a cathode is placed on the skull of the patient and an appropriate electric field is applied between the anode and cathode. The use of a vacuum within the device to remove the destructive charged particles.
REFERENCES:
patent: 4503863 (1985-03-01), Katims
patent: 6001088 (1999-12-01), Roberts
patent: 6077237 (2000-06-01), Campbell
patent: 6410046 (2002-06-01), Lerner
patent: 6591138 (2003-07-01), Fischell
patent: 6678553 (2004-01-01), Lerner
patent: 7244769 (2007-07-01), Epstein
patent: 2002/0123678 (2002-09-01), Lerner
patent: 2002/0183683 (2002-12-01), Lerner
patent: 2003/0125786 (2003-07-01), Gliner et al.
patent: 2004/0210269 (2004-10-01), Shalev
patent: 2005/0065574 (2005-03-01), Rezai
patent: 2005/0159790 (2005-07-01), Shalev
patent: 2006/0106430 (2006-05-01), Fowler
Davalos, “Duration of glutamate release after acute ischemic stroke”, Stroke, (Apr. 1997), pp. 708-710, vol. 28 —abstract.
Finefrock, “Current Status of Metals as Therapeutic Targets in Alzheimer's Disease”,J. Am. Geriatr. Soc., (2003), pp. 1143-1148, vol. 51, The American Geriatric Society.
Gupta, “Aluminium in Alzheimer's disease: are we still at a crossroad?”,Cell Mol. Life Sci., (Jan. 2005), pp. 143-58, vol. 62(2)-abstract.
Huang, “Alzheimer's Disease, Protein and Zinc1,2”,J. Nutrition(May 2000), pp. 1488S-1492S, vol. 130(5S Supp.), American Society for Nutritional Sciences.
Lerner, “Enhanced Delivery of Octreotide to the Brain via Transnasal Iontophoretic Administration”,J. Drug Targeting, (Jun. 2004), 12(5) 273, Taylor & Francis Ltd.
Mancia,“Prevention and treatment of stroke in patients with hypertension”,Clin. Ther., (2004, May), pp. 631-48, vol. 26(5), Excerpta Medica.
Nagasawa, “Transport mechanism for aluminum citrate at the blood—brain barrier: kinetic evidence implies involvement of system Xc—in immortalized rat brain endothelial cells”,Toxicology Letters, (2005), pp. 289-296, vol. 155, Elsevier Ireland Ltd.
Yokel, “Aluminum citrate uptake by immortalized brain endothelial cells: implications for its blood—brain barrier transport”,Brain Research, (2002), pp. 101-110, vol. 930, Elsevier Science B.V.
Yokel, “Entry, Half-Life, and Desferrioxamine-Accelerated Clearance of Brain Aluminum after a Single 26A1 Exposure”,Toxicol. Sciences, (2001), pp. 77-82, vol. 64, The Society of Toxicology.
Yokel, “Brain Uptake, Retention, and Efflux of Aluminum and Manganese”,Env. Health Persp., (Oct. 2002), pp. 699-704, vol. 110(Supp. 5).
Codman & Shurtleff Inc.
DiMauro Thomas M.
Layno Carl H
Stice Paula J
LandOfFree
Device for removing deleterious charged molecules from brain... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Device for removing deleterious charged molecules from brain..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Device for removing deleterious charged molecules from brain... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2764256